In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....